Evidence map›Paper›PMID 40923372›Full record

ArticleAnalytical chemistry2025

Monitoring Molecular Uptake and Cancer Cells' Response by Development of Quantitative Drug Derivative Probes for Chemical Imaging.

Pei-Hsuan Hsieh, Shu-An Hsieh, Craig Richard, Kannanganattu V Prasanth, Jared L Anderson, Rohit Bhargava

Abstract read
In one paragraph

Article in Analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pei-Hsuan HsiehDepartment of Bioengineering, University of Illinois Urbana-Champaign, Urbana, Illinois 61801, United States.
Shu-An HsiehDepartment of Chemistry, Iowa State University, Ames, Iowa 50011, United States.
Craig RichardDepartment of Bioengineering, University of Illinois Urbana-Champaign, Urbana, Illinois 61801, United States.
Kannanganattu V PrasanthCancer Center at Illinois, University of Illinois Urbana-Champaign, Urbana, Illinois 61801, United States.
Jared L AndersonDepartment of Chemistry, Iowa State University, Ames, Iowa 50011, United States.ORCID 0000-0001-6915-8752
Rohit BhargavaDepartment of Bioengineering, University of Illinois Urbana-Champaign, Urbana, Illinois 61801, United States.ORCID 0000-0001-7360-994X

Funding

The Center for Label-free Imagingand Multiscale Biophotonics (CLIMB)P41EB031772 · NIBIB · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI Stephen A Boppart · 2022 to 2026
$7.6M
Discrete Frequency Infrared Spectroscopic Imaging for Breast HistopathologyR01EB009745 · NIBIB · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI BHARGAVA, ROHIT · 2010 to 2025
$5.1M
Tissue microenvironment (TIMe) training programT32EB019944 · NIBIB · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI BHARGAVA, ROHIT, GASKINS, REX · 2016 to 2025
$1.9M
Characterization of nuclear-retained RNA-mediated gene regulatory mechanismsR01GM132458 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI KANNANGANATTU, PRASANTH KUMAR VIJAYAN · 2020 to 2023
$1.4M
Monoalleleic autosomal spreading of a novel family of nucleolus-localized ncRNAsR21AG065748 · NIA · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI KANNANGANATTU, PRASANTH KUMAR VIJAYAN · 2020 to 2021
$423k
NIA NIH HHS R21 AG065748NIBIB NIH HHS P41 EB031772NIBIB NIH HHS R01 EB009745NIBIB NIH HHS T32 EB019944NIGMS NIH HHS R01 GM132458
6 · The paper itself

Abstract

Infrared (IR) spectroscopic imaging combines the molecular specificity of vibrational spectroscopy with imaging capabilities of microscopy, potentially allowing for simultaneous quantitative observations of drugs and cellular response. However, accurately quantifying drug concentration within changing cells is complicated by the overlap between exogenous molecules' and native cellular spectra. Here, we address this challenge by developing a derivative of the widely used chemotherapeutic doxorubicin as a spectral bioprobe (DOX-IR) using a strongly absorbing metal-carbonyl moiety [(Cp)Fe(CO)

Indexed as

Antineoplastic AgentsDoxorubicinMolecular ProbesCell Line, TumorHumansSpectrophotometry, InfraredAntineoplastic AgentsDoxorubicinMolecular Probes

Identifiers

PMID40923372
PMCPMC12788957

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.